Eye care providers worldwide are under pressure to deliver consistent, engaging, and scalable care for functional eye conditions. Whether the challenge is visual function training, pediatric eye health, or the growing demand for digital care pathways, clinics and distributors need solutions that combine clinical relevance with practical deployment. Guangzhou Shijing Medical Software Co., Ltd. ("Shijing Medical") addresses this need through digital diagnosis and treatment technologies built for ophthalmology and optometry.
Who We Are
Founded in 2008, Shijing Medical is a medical technology company focused on innovation in ophthalmology and optometry. The company invests in artificial intelligence, image analysis, and virtual reality, with a clear goal: to become a leader in full-life-cycle solutions for functional eye diseases. Its portfolio includes two core digital diagnosis and treatment solutions: DOBOSO, a visual function training solution, and BaBy Blissful, a PBM photobiomodulation solution.
These solutions are widely used in more than 3,000 eye hospitals and optometry centers across China, as well as in home therapy settings. Cumulative use has exceeded 500,000 people, with positive feedback from clinicians and patients’ parents. Among comparable products, Shijing Medical’s market share has remained industry-leading.
Product Portfolio: DOBOSO and BaBy Blissful
DOBOSO is a digital diagnosis and treatment solution for visual function training. It brings together AI, image analysis, and VR to support structured visual function training in clinical and home environments. For eye hospitals, optometry chains, and distribution partners, DOBOSO offers a technology-enabled way to organize and deliver visual function training programs within modern eye care workflows.
BaBy Blissful is a PBM photobiomodulation digital diagnosis and treatment solution. As part of the Shijing Medical portfolio, it extends the company’s focus on functional eye care into light-based digital care. Together, DOBOSO and BaBy Blissful reflect a portfolio approach: different technologies, shared clinical focus, and flexibility across hospital, optometry center, and home therapy scenarios.
Technology, Research, and Industry Leadership
Shijing Medical has built a substantial intellectual property portfolio, with more than 200 intellectual property assets deployed and more than 60 authorized invention patents. The company continues to invest in AI, image analysis, and VR, and has received provincial key R&D project approvals. It has also carried out clinical trials and research collaborations with multiple well-known medical institutions, contributing to the advancement of ophthalmic care.
Beyond product development, Shijing Medical leads or participates in the development of team and industry standards, including the VR Visual Training System Technical and Application Specification. The company has co-published important industry research reports, including the 2026 Blue Book on the Development Status and Future Trends of Myopia Management for Children and Adolescents, the Blue Book on the Current Status of Digital Treatment for Children’s Strabismus and Amblyopia in China, and the White Paper on the Current Status of Digital Treatment for Children’s Strabismus and Amblyopia in China. These initiatives support the stable and professional development of the visual health industry.
Shijing Medical has received recognition including selection for the Guangzhou Pre-IPO High-Tech Enterprise Reserve Top 100 list, the Deloitte China Rising Star list, the China Digital Therapeutics Top 10, the Global Ophthalmology Clinical Application Award, and the China Visual Function Training Leading Brand award. These recognitions reflect the company’s long-term commitment to clinical value, innovation, and industry collaboration.
Application Scenarios for Overseas Buyers and Distributors
Shijing Medical’s solutions are designed for real-world eye care settings. Key application scenarios include:
Eye hospitals and clinics: Integrate digital visual function training and PBM photobiomodulation solutions into ophthalmology and optometry service lines, supporting clinicians with technology-enabled care delivery.
Optometry centers and retail eye care networks: Offer structured, digitally delivered visual function training programs that can complement professional eye care services and improve patient engagement.
Home therapy programs: Extend care beyond the clinic through home-based therapy scenarios, helping providers support continuity between professional visits.
Pediatric and functional eye care programs: Align with growing attention to children’s myopia management, strabismus and amblyopia digital treatment, and lifelong visual function care. Shijing Medical’s involvement in industry standards, clinical research, and blue book reports provides a strong foundation for partners building credible eye care offerings.
Industry Insight: Why Digital Eye Care Is Gaining Momentum
Functional eye diseases and pediatric vision conditions often require long-term management, consistent follow-up, and patient/family engagement. Traditional care models can be limited by access, geography, clinician time, and variation in therapy delivery. Digital therapeutics, VR-based training, image analysis, and photobiomodulation are creating new options for making care more structured, accessible, and engaging.
For distributors and importers, the opportunity is not simply to add another product. It is to partner with a company that combines clinical adoption at scale, a focused product portfolio, a strong IP position, standards participation, and industry recognition. Shijing Medical’s experience across more than 3,000 eye hospitals and optometry centers, together with more than 500,000 cumulative users, demonstrates real-world deployment beyond a single pilot setting. This matters when buyers evaluate long-term supplier credibility and category potential.
Why Partner with Shijing Medical
International partners look for suppliers with a clear clinical focus, differentiated technology, and evidence of market trust. Shijing Medical offers:
Focused expertise: Since 2008, the company has concentrated on ophthalmology and optometry, with a mission to lead in full-life-cycle functional eye disease solutions.
Two complementary product lines: DOBOSO for visual function training and BaBy Blissful for PBM photobiomodulation, covering multiple digital care scenarios.
R&D depth: More than 200 intellectual property assets, more than 60 authorized invention patents, and provincial key R&D project approvals.
Clinical and industry collaboration: Clinical trials and research projects with well-known medical institutions, plus participation in standards and major industry reports.
Market recognition: Industry-leading market share among comparable products and multiple awards in digital therapeutics, ophthalmology application, and visual function training.
Contact Shijing Medical
If you are an overseas distributor, importer, clinic group, or healthcare partner seeking digital therapeutics and VR-enabled solutions for functional eye care, Shijing Medical welcomes the opportunity to discuss collaboration. We invite you to learn more about DOBOSO, BaBy Blissful, and our approach to ophthalmology and optometry innovation.
Website: www.shijingmed.com
Email: fangtao@topeye.cn
Phone: +86 4008777511 / +86 15021168718
WeChat: yesmylord123
Contact us today to explore distribution, clinical collaboration, and regional partnership opportunities in functional eye care.